Influence of phase I periodontal therapy on levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1
Matrix metalloproteinase-1 (MMP-1) is a member of a family of enzymes
that can degrade most extracellular matrix macromolecules. Extracellularly, MMPs are controlled
by tissue inhibitors of metalloproteinases (TIMPs) and by mechanisms of pro-MMP activation.
Levels of MMPs and TIMPs change during healing, inflammation, and normal tissue turnover.
Herein we aimed to evaluate the levels of MMP-1 and TIMP-1 in gingival crevicular fluid (GCF)
from periodontally healthy patients (control group) and chronic periodontitis patients before and
after phase 1 therapy.
that can degrade most extracellular matrix macromolecules. Extracellularly, MMPs are controlled
by tissue inhibitors of metalloproteinases (TIMPs) and by mechanisms of pro-MMP activation.
Levels of MMPs and TIMPs change during healing, inflammation, and normal tissue turnover.
Herein we aimed to evaluate the levels of MMP-1 and TIMP-1 in gingival crevicular fluid (GCF)
from periodontally healthy patients (control group) and chronic periodontitis patients before and
after phase 1 therapy.